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Receptors for the Fc portion of IgG (FcRs)' play a role in mediating both
normal and pathologic immunophagocytosis. One FcR on human cells (termed
CD16 by the International Workshop on Human Leukocyte Differentiation
Antigens) (1) is present on the surfaces of neutrophils, NK cells, and resident
macrophages, but is absent from the surfaces ofperipheral blood monocytes (2).
CD16, recognized by mAbs 3G8 (2), Leu 11 (3), and B73.1 (4), binds immune
complexes efficiently, but does not bind monomeric IgG. CD16 on neutrophils
exhibits broad electrophoretic mobility (50,000-73,000 daltons) after SDS-
PAGE, which suggests that it contains abundant carbohydrate. Previous studies
in chimpanzees demonstrated that this receptor plays an important role in
removal of model immune complexes from the circulation (5). Moreover, infu-
sion ofanti-CD16 mAbs into patients with refractory immunethrombocytopenic
purpura transiently raised platelet counts, suggesting a role for CDI6-mediated
phagocytosis in the pathogenesis ofthis disease (6). However, very little is known
about this receptor on normal human macrophages. In thisstudy, we investigated
the expression, structure, and function of CD16 on monocytes during their
differentiation in culture to macrophage-like cells.
Materials and Methods
Preparation of Peripheral Blood Monocytes and Neutrophils.
￿
Blood was obtained from
normal human volunteers, anticoagulated with acid/citrate/dextrose, and then subjected
to centrifugation on Ficoll-Hypaque to separate mononuclear cells and neutrophils (7).
Monocytes were subsequently separated from lymphocytes by the method ofRecalde (8).
Briefly, mononuclear cells were incubated in hypertonic saline and then centrifuged for
30 min at 600 g over Ficoll-Hypaque (density of 1.078) to which had been added 2.8
mg/ml ofNaCl. Monocytes remained buoyant and lymphocytes pelleted to the bottom of
the tube. Monocytes were 80-95% pure asjudged by Wright staining and nonspecific
esterase staining. Neutrophils were further purified by dextran sedimentation. Prepara-
tions typically contained >95% neutrophils asjudged by Wright staining.
Cultivation and Stimulation of Monocytes.
￿
Monocytes were seeded into Teflon dishes
(Savillex Corp., Minnetonka, MN) in RPMI 1640 (Flow Laboratories, Inc., McLean, VA)
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containing 10% human serum and 2% FCS at 1 X 106 cells/ml. Cell numbers decreased
with time in culture, ranging from 2.5 to 7.3 X 105/ml (mean 3.9 X 105/ml) at 14 d. To
stimulate expression of FcRs, human rIFN-'Y (a generous gift of Dr. Michael Shepard,
Genentech Inc., So. San Francisco, CA) was added to freshly isolated monocytes in the
amounts indicated in Results.
Monoclonal Antibodies.
￿
The cell line producing mAb 3G8 (IgGI) (2), was a generous
gift of Dr. Jay C. Unkeless, Mt. Sinai Medical School, New York. Ascites containing mAb
IB4 (IgG2a) (9) was a generous gift of Dr. Samuel D. Wright, The Rockefeller University,
New York. Ascites containing 32 .2 (20) was a generous gift of Dr. Michael Fanger,
Dartmouth School of Medicine, Hanover, VT. Purified mAb 3C10 (IgG2b) (10) was a
generous gift of Dr. Ralph Steinman, The Rockefeller University, New York. IV3 culture
supernatant (IgG2b) (11) was a generous gift of Dr. John Looney, University of Rochester
Medical School, Rochester, NY. Cell linesproducing MOPC-21 (murine IgGI myeloma),
4172C13 (IgGI) (12), and 63D3 (IgG1) (13) were obtained from American Type Culture
Collection, Bethesda, MD. Purified RPC-5 (murine IgG2a myeloma) was obtained from
Litton Bionetics, Kensington, MD. mAbs were purified from ascites by precipitation with
45% saturated ammonium sulfate, followed by precipitation with caprylic acid (1 .5%,
vol/vol) (Sigma Chemical Co., St. Louis, MO) (14). Fab fragments were prepared by
digestion with immobilized papain (Sigma Chemical Co.), and then purified by passage
over protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) at pH 8.3. No
contamination with Ig heavy chain was detected by SDS-PAGE.
Immunoassays. Cultured monocytes (0 .5-1 .0 X 106 cells/tube) were harvested from
Teflon dishes, washed in PBS, and then incubated in PBS for 1 h at room temperature
to remove cell surface IgG adsorbed from culture media. Subsequent examination by
immunofluorescence microscopy using fluorescenn-conjugated goat anti-human Ig Qack-
son Immunoresearch, Avondale, PA) revealed no evidence of surface-bound Ig. Cells
were then incubated for 30 min at 4°C with either purified Fab fragments of mAbs (10
wg/ml) or 30 kl culture supernatants (as indicated in Results). After washing, cells were
incubated for 30 min at 4°C with F(ab')2 goat anti-mouse Ig conjugatedto FITC (Jackson
Immunoresearch). After washing again, cells either were allowed to settle onto poly-L-
lysine (100 ug/ml)-coated masked slides (Carlson Scientific, Inc., Peotone, IL) and
examined by fluorescence microscopy, or were examined by flow cytometry using a
cytofluorograph II (Ortho Diagnostic Systems, Inc., Westwood, MA). The cytofluorom-
eter was calibrated each day with Fluorosphere Fullbright Gr. II fluorescent beads(Coulter
Diagnostics, Hialeah, FL). Monocyte fractions were selected on the basis of size and
granularity, and contaminating lymphocytes were gatedout. Peak channels offluorescence
varied <10% between days.
For binding assays with radiolabeled mAbs, 0.5-1 .0 X 106 cells were incubated at 4°C
with equal volumes of "'I-labeled mAbs (2 .5 wg/ml) and either PBS containing 1 .0 mg/ml
BSA (PBS/BSA) or unlabeled mAb (1 .0 mg/ml). After 30 min, cells were suspended in
0.5 ml of cold PBS/BSA and layered over 0.5 ml Versilube F50 silicon oil (General
Electric, Waterford, NY) contained in 1 .5 ml polypropylene microfuge tubes, and centri-
fuged for 5 min at 10,000 g. After removing the aqueous and oil phases by aspiration,
tips of tubes containing cell pellets were excised and subjected to gamma counting. Specific
binding was determined by subtracting radioactivity that became cell associated in the
presence of excess unlabeled antibody from total radioactivity.
Immunoprecipitation. 2-4 X 10' cultured monocytes or freshly isolated neutrophils
were surface labeled with "'I using lodogen (25 ag/tube) (Pierce Chemical Co., Rockford,
IL), and then lysed in PBS containing 10 mM octyl-thioglucoside, 1 .0 mM diisopropyl-
fluorophosphate, 1 .0 mM PMSF, and 0.02% (wt/vol) sodium azide. Postnuclear superna-
tants of lysed cells were then incubated sequentially at 4'C with BSA coupled to Sepharose
4B (Pharmacia Fine Chemicals) and mAbs coupled to Sepharose 4B (each for 2 h).
Sepharose beads were washed extensively, resuspended in sample buffer containing 10%
(vol/vol) glycerol, 1 .0% (vol/vol) 2-ME, 2.0% (wt/vol) SDS, 0.001% (wt/vol) bromphenol
blue, and 62.5 mM Tris, pH 6.5, boiled for 3 min, and then subjected to SDS-PAGE
followed by autoradiography.410
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Treatmentwith Glycosidases.
￿
For digestion with glycosidases, immunoprecipitates were
eluted from resuspended Sepharose beads by boiling for 3 min. Treatment with N-
glycanase (Genzyme, Boston, MA) was carried out in 0.25 M sodium borate (pH 8.6)
containing 0.5% SDS, 10 mM 1,10 phenanthroline (Sigma Chemical Co.), and 1 .0% NP-
40 (vol/vol). Treatment with endoglycosidase H (Endo H; Boehringer Mannheim Bio-
chemicals, Indianapolis, IN) was carried out in 0.1 M sodium citrate (pH 5.5) containing
0.1 % SDS (wt/vol). Treatment with endoglycosidase D (Endo D; Boehringer Mannheim
Biochemicals) was carried out in 0.1 M sodium phosphate (pH 6.5) containing 0.1 % SDS
(wt/vol). Enzymes were added and mixtures were incubated overnight at 37 °C. After
incubation with glycosidases, reaction mixtures were boiled for 3 min to inactivate
enzymes, and then subjected to SDS-PAGE followed by autoradiography. 1 U of Endo D
and Endo H is defined as the amount of enzyme required to release 1.0 umol of
carbohydrate from appropriate substrates. 1 U of N-glycanase is defined as the amount
of enzyme required to release 1.0 nmol of carbohydrate from appropriate substrates.
Enzymatic activity of glycosidases was confirmed by digestion of fetuin (100 ug/ml) by
Endo H (30 mU/ml) and Endo D (30 mU/ml); of DNAase (100 ug/ml) by Endo H; and
of RNase (100 ug/ml) by Endo D. Digestion was confirmed by subjecting glycoproteins
to SDS-PAGE. Decreases in apparent M, were interpreted as being due to deglycosylation.
Attachment and Phagocytosis of IgG-coated Erythrocytes.
￿
Inhibition studies performed
with antibodies in solution were performed as follows. Freshly isolated monocytes and
monocytes that hadbeen cultured for 14 d (1 X 106 cells/ml) were applied to polystyrene
plates coated with poly-L-lysine (100 ug/ml) (Sigma Chemical Co.) and allowed to adhere
at room temperature. RPMI with 5% FCS was added to monolayers for 30 min at 4°C.
Sheep erythrocytes (RBCs) that had been previously coated with rabbit anti-sheep RBC
IgG (final concentration, 0.25% ; Cordis Laboratories Inc., Miami, FL) and mAbs (10
jig/ml) were then added and incubated for I h at 4°C. Attachment of IgG-coated RBCs
to monocytes was scored by phase-contrast microscopy using a 40X water immersion lens
(Nikon,Japan). Monolayers were then incubatedat 37'C for 1 h, afterwhichnoningested
RBCs were lysed by briefexposure to distilled water. Phagocytosis was then measured as
above. Results are reported as attachment index or phagocytic index; i .e., the number of
RBCs bound or ingested per 100 monocytes.
Inhibition studies also were performed with antibodies in the solid phase as described
above with the following modification. Terasaki plates were coated with mAbs (50 ug/ml)
or media for 2 hat room temperature. Afterwashing, monocytes were added andallowed
to adhere for 1 h at 37°C, before adding IgG-coated RBCs.
Results
Monocytes Change Both Morphologically andPhenotypically as aFunction ofLength
of Time in Culture. Human peripheral blood monocytes appeared to mature in
culture and to develop features characteristic ofmacrophages. By day 7, cultured
cells gradually lost the morphology, cell size (12-16 um), and cytoplasm/nucleus
ratio typical offreshly isolated monocytes (15), and developed features ofmature
macrophages with more-rounded nuclei, larger cell size (40-80 um), and cyto-
plasm/nucleus ratios of -3:1 . Giant cells (1-4%) began to appear at day 7 and
increased in number with time in culture to 4-12% by day 18. Phenotypically,
freshly isolated monocytes expressed epitopes recognized by mAb IB4 (comple-
ment receptor type 3, or CR 3) (9), as well as epitopes recognized by rnAb
4172C13 and 3C10, which are found on both monocytes and macrophages (10,
12). Freshly isolated monocytes also expressed the epitope recognized by mAb
63D3, which is found on monocytes, but not on macrophages (13). Over a period
of 18 d in culture, monocytes exhibited no changes in the level ofexpression of





















Binding of mAb 3G8 Fab to mono-
cytescultured for 18 d. Monocytescultures for 18
d were tested at the indicated time points for
reactivity with mAb 3G8 Fab (10 gglml) by indi-
rect immunofluorescence. Reactivity graduallyin-
creased until day 10 when ^-100% of cells were
positive. Similar results were obtained by flow cy-
tometry. Results represent mean values obtained
inexperiments usingcells from 10 different donors
tested sequentially over 18 d.
FIGURE 2. Cell surface density of CD16 and
FcRp72 on cultured monocytes. Monocytes were
cultured for 10 d, and then binding assays were
performed at 2-d intervals for 14 d. 125I-labeled
3G8 Fabwas used fordeterminations of CD16 and
'251-labeled murine IgG2a was used for determi-
nations of FcRp72 . Cell surface density of CD16
(closed circles) increased as a function of length of
time in culture, while cell-surface density of FcRp72
(open circles) remained approximately the same.
Results represent mean values obtained in six sep-
arateexperiments.
mAb 63D3. Therefore, monocytes appeared to differentiate in culture to mac-
rophage-like cells both morphologically and phenotypically,
Expression of CD16, but not Other Types ofFcRs, Increases with Cellular Differen-
tiation. CD16 is not expressed on the surface of peripheral blood monocytes
(2). Nonetheless, immunocytochemical staining of sections of both human liver
and human spleen has revealed reactivity with mAb 3G8 in a pattern consistent
with the distribution of resident macrophages (6). Previous work revealed that
15% of cultured monocytes react with anti-CD16 mAb 3G8 on day 6 (16). We
further investigated expression ofCD16 on cultured monocytes. With increasing
time in culture, both the percentage of cells expressing CD16 and the number
ofsites per cell increased. Immunofluorescence assays revealed that the percent-
age of cells recognized by mAb 3G8 increased to ^-100% by day 10 (Fig. 1).
Therefore, expression of CD16 increases as monocytes differentiate into mac-
rophages both in vivo and in vitro.
FcRs for IgG can be classified according to their ability to bind monomeric
IgG. Although all FcRs bind immune complexes, only FcRs with an apparent Mr
of 72,000 (FcRp72) (2, 17) can bind monomeric IgG. CD16 and an FcR with an
apparent Mr of 40,000 (CDw32) (1, 11) bind only immune complexes. We
measured cell surface expression of these three different FcRs (FcR p72, CDw32,
andCD16) on cultured human monocytes. Radioimmunoassays using 125I-labeled
mAb 3G8 demonstrated that the cell surface density ofCD16 increased from a
mean of 14,820 sites per cell on day 10 to a mean of43,680 sites per cell on day
24 (Fig. 2). (Assays for CD16 were not performed until ^-100% of cells were
positive by immunofluorescence.) When assessed by binding of '25I-labeled
monomeric IgG2a, the level ofexpression ofFcRp72on monocytes did not change
with differentiation in culture. Freshly isolated monocytes (data not shown), as
well as monocytes examined at 2-d intervals from day 10 to day 24, possessed
-10,000 sites per cell.41 2
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FIGURE 3. Expression of CDw32 compared
to expression of CD16 on cultured monocytes.
Monocytes were isolated from blood, and then
tested for reactivity by indirect immunofluores-
cence and flow cytometry with control-irrele-
vant myeloma protein (dotted lines) or with
mAbs (solid lines). A-C demonstrate reactivity
with anti-CDw32 mAb IV3 on days 0, 8, and
18, respectively. D-F demonstrate reactivity
with mAb 3G8 on days 0, 8, and 18, respec-
tively. Expression of CDw32 appeared to de-
crease with respect to thepercentage ofpositive
cells and in the relative intensity of fluores-
cence. The number of positive cells decreased
from 91.4% (freshly isolated monocytes) to
50.1% (day 8) to 22.2% (day 14) with a pro-
gressively decreasing peak channel of fluores-
cence. In contrast, the level of expression of
CD16 progressivelyincreasedfrom 0% positive
(day 0),to 64% (day 8), to 97% (day 18).Results
shown were obtained with monocytes from a
single donor, and are representative of results
obtained in two other experiments using cells
from two other donors.
Surface expression of CDw32 on monocytes actually decreased with time in
culture. Fig. 3 demonstrates reactivity ofanti-CDw32 mAb IV3 and anti-CD16
mAb 3G8 with freshly isolated monocytes, as well as with monocytes cultured
for 8 dand 18 d. Expression ofCDw32 decreased with respect to both percentage
of positive cells and cell surface density, while expression ofCD16 increased. It
appears, therefore, that CD16 is the predominant FcR on differentiated mono-
cytes.
Agents That Promote Expression of FcRp72 Do Not Promote Expression of
CD16. IFN-y can induce new expression ofcertain surface antigens (e.g., class
II histocompatibility antigens) (18)and can increase surface expression ofothers.
The surface expression of FCRp72 on monocytes and U937 cells increases 8-10-
fold after treatment of cells with IFN-y (19). This increase correlates with an
increase in the ability of U937 cells to generate superoxide anion radicals after
stimulation with either immune complexes or anti-FcRp72 mAbs (20). We were
interested in determining whether expression ofCD16 also is regulated by IFN-
y. Freshly isolated monocytes were incubated with human rIFN-y (1-1,000
U/ml), and then assayed for expression of CD16 and FcRp72 . Cells from 35 of
35 normal blood donors demonstrated increases in numbers of sites per cell of
at least fivefold in expression of FcRp72 after treatment with greater than 10
U/ml of IFN-y, increasing from 11,438 (q 2,478) to 82,734 (q 10,456). In
contrast, cells from only 2 of 35 donors demonstrated measurable numbers of
CD16 with comparable doses. Monocytes from these two individuals, however,
were reproducibly induced to express CD16 after 24 h in culture with IFN-y.TABLE I
Effect ofmAbs in Solution on Bindingand InternalizationofIgG-coated RBCs by Freshly




Freshly isolated and 14-d-old monocytes were plated at 1 x 106 cells/ml on Terasaki plates that
had been previously coated with poly-L-lysine (100 ug/ml) as described in Materials and Methods.
Cells were allowed to adhere for 1 hat 37°C, before antibodies (10,ug/ml) and sheep RBCs coated
with rabbit anti-sheep RBCs were added. After 1 h at 4°C, nonadherent cells were removed and
rosettes counted. Plates were then incubated at 37°C for 1 h, and RBCs that had not been
internalized were removed by hypotonic lysis. Internalized RBCs were then counted.
* Number of RBCs bound per 100 cells.
Number of RBCs ingested per 100 cells.
§ Results represent means of triplicate wells in experiments usingcells from twoseparate donors.
Nearly 100% of monocytes from both individuals were positive as determined
by immunofluorescence, and for the one individual tested, there were 10,400
sites/cell. However, IFN-1' failed to induce expression ofCD16 on most normal
donors.
CD16 on Cultured Monocytes CanMediate Phagocytosis.
￿
Very little information
is available concerning the individual contribution of each type of FcR to ligand
binding and internalization by human mononuclear phagocytes. Consequently,
we performed the following experiments to determine whether both CD16 and
FcRp72 could independently mediate attachment and phagocytosis of IgG-coated
RBCs. Studies of inhibition of ligand binding and phagocytosis by mABs were
performed in two ways, with mAbs in solution and with mAbs in the solid phase
(coated onto culture dishes). When mAbs and IgG-coated RBCs were added
simultaneously to freshly isolated monocytes on poly-L-lysine-coated culture
dishes, IgG2a (10 /Ag/ml) had a small inhibitory effect on ligand attachment and
phagocytosis, while mAbs 3G8 and IV.3 had no effect (Table I). When 14-d-old
monocyteswere studied, 3G8 Fabhada marked inhibitoryeffect onphagocytosis.
While neither 3G8 nor IgG2a added as single agents were able to completely
inhibit binding or phagocytosis, the combination of the two antibodies was
completely inhibitory.
When freshly isolated and 14-d-old monocytes were plated onto dishes coated
with mAbs, similar results were obtained (Table 11). In these experiments, cell
surface receptors migrate to, and are bound by, the mAbs and become unavail-














Media 549 310 988 472
MOPC 21 (IgG 1) 598 305 983 501
4F2C13 512 217 1,042 512
3G8 Fab 601 343 542 103
RPC-5 (IgG 2a) 444 195 288 301
IV.3IgG 561 348 937 444
3G8 Faband RPC-5 382 343 107 55
3G8 Fab and IV.3 528 352 357 120
RPC-5 and IV.3 324 202 298 301
RPC-5, 3G8 Fab, and IV.3 277 204 98 4041 4
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TABLE II
Effect ofSolid Phase mAbs on Binding and Internalization ofIgG-coated RBCs by Freshly
Isolated, and 14-d-old Monocytes
Freshly isolated and 14-d-old monocytes were plated at 1 x 106 cells/ml on Terasaki plates that
hadbeen previously coated with antibodies (50 t+g/ml) as described in Materialsand Methods. Cells
were allowed to adhere for I h at 37°C, before sheep RBCs coated with rabbit anti-sheep RBCs
were added. After 1 hat 4°C, nonadherent RBCs were removedandrosettes counted. Plates were
then incubated at 37 °C for 1 h, and RBCs that had not been internalized were removed by
hypotonic lysis. Internalized RBCs were then counted.
* Number of RBCs bound per 100 cells.
$ Number of RBCs ingested per 100 cells.
Results represent means of triplicate wells of two separate donors.
were not significantly inhibited when freshly isolated monocytes were added to
surface-bound IgG2a, IV. 3, or 3G8. Although both 3G8 FabandIgG2ainhibited
ligand binding to a moderate degree by 14-d-old monocytes, only mAb 3G8
markedly inhibited phagocytosis. These findings suggest that whereas both
FcRp72 and CD 16 are capable of mediating attachment of IgG-coated RBCS,
CD16 may play a more important role than do FcR.72 or CDw32 in mediating
internalization.
CD16 on Cultured MonocytesDiffersfrom CD16 on Neutrophils.
￿
Various murine
cell types express FcRs that share antigenic determinants but differ in apparent
M, (Pure, E., personal communication) . Consequently, we compared the structure
of CD 16 on human neutrophils with the structure of CD 16 on cultured mono-
cytes. Immunoprecipitates prepared from surface-labeled, freshly isolated neu-
trophils and from surface-labeled, 10-d-old monocytes had the typical heteroge-
neous appearance of CD 16 on autoradiograms after SDS-PAGE (Fig. 4). Neutro-
phils CD16 appeared as a broad band from ^-50-73 kD. However, CD16 on
cultured monocytes was represented by a predominant band at ^-53 kD with less
heterogeneity. In some experiments, other bands at 40 and 31 kD were also
immunoprecipitated, but these were not consistently present. Therefore, as in
the murine system, antigenically similar FcRs from human cells also appear to
be structurally heterogeneous.
To determine whether differences in glycosylation accounted for this hetero-
geneity, immunoprecipitates prepared from lysates of surface-labeled neutrophils














Media 400 214 734 412
MOPC 21 (IgG 1) 402 237 741 452
4172C13 482 274 794 453
3G8 Fab 399 219 452 104
RPC-5 (IgG 2a) 201 101 471 252
IV.3IgG 449 333 798 454
3G8 Faband RPC-5 243 140 45 18
3G8 Faband IV.3 490 255 404 89
RPC-5 and IV.3 298 113 428 204
RPC-5, 3G8 Fab, and IV.3 280 102 62 10CLARKSON AND ORY
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FIGURE 4. Immunoprecipitation of CD16 from neutro-
phils and cultured monocytes. Neutrophils (A) and mono-
cytes cultured for 10 d (B) were surface labeled with "5I,
and then lysed . Lysates were incubated with either MOPC
21-Sepharose (lane 1) or 3G8 Fab-Sepharose (lane 2), and
then subjected to SDS-PAGE on a 10% gel, followed by
autoradiography . 5,000 cpmwas applied to lane2in both A
andB. CD16 from neutrophils appeared to be more hetero-
geneous in size than CD16 from cultured monocytes, which
was represented by a predominant band at -53 kD .
FIGURE 5 . Neutrophil CD16 is sensi-
tive to digestion with N-glycanase . '251
surface-labeled neutrophils were lysed,
and lysates immunoprecipitated with
3G8 Fab-Sepharose . CD16 was treated
with sample buffer (lane 1) ; N-glycanase,
1, 10, or 30 U/ml (lanes 2-4, respec-
tively) ; Endo H, 10, 30 or 100 mU/ml
(lanes S-7, respectively) ; and Endo D,
15, 40, or 150 mU/ml (lanes 8-10, re-
spectively) . Reaction mixtures were then
subjected to SDS-PAGE as in Fig. 4 .
Digestion with N-glycanase, but not
Endo H or Endo D effected a decrease
in the M, ofCD16 .
SDS-PAGE . Neither Endo D (15-150 mU/ml) nor Endo H (10-100 mU/ml)
altered the apparent M,. of CD16 from neutrophils (Fig . 5) . This suggests that
both high mannose (Endo H-sensitive) (21) and more complex (Endo D-sensi-
tive) (22) oligosaccharides either are not attached to neutrophil CD 16 or are not
accessible for cleavage by these enzymes . Control glycoproteins were successfully
digested by both enzymes in parallel experiments (see Materials and Methods) .
However, after treatment of neutrophil CD 16 with N-glycanase (as little as 10
U/ml), which hydrolyzes glycosidic links at asparagine residues (23), protein
bands with apparentM r's of 31 and 29 kD appeared . CD16 on cultured mono-
cytes was similarly unaffected by treatment with Endo D and Endo H (Fig . 6) .
Treatment with N-glycanase (1-100 U/ml), however, also did not affect the
appearance of the predominant 53-kD band . To confirm that N-glycanase was
enzymatically active, CD16 immunoprecipitated from neutrophils was treated in
parallel with CD16 immunoprecipitated from monocytes. Again, only CD16
from neutrophils was digested to the molecular mass species described above .
To confirm that N-glycanase is capable of digesting carbohydrates on monocyte
surface proteins, FcRp72was immunoprecipitated from cultured monocytes using
mAb 32 .2 (20), then treated with N-glycanase (Fig . 7) . FcRp72 reproducibly416
￿
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FIGURE 6. Treatment of CD16
from cultured monocytes with gly-
cosidases . Immunoprecipitates of
CD16 from monocytes cultured for
10 d were prepared as in Fig. 5 .
CD16 was treated with sample buffer
(lane 1) ; N-glycanase, 1, 10, or 30
U/ml (lanes 2-4, respectively) ; Endo
H, 10, 30, or 100 mU/ml (lanes 5-7,
respectively) ; and Endo D, 15, 40, or
150 mU/ml (lanes 8-10, respec-
tively) . None of the glycosidases se-
lected caused a decrease in the M, of
CD16 from cultured monocytes . Re-
action mixtures were then subjected
to SDS-PAGE as in Fig . 5 .
FIGURE 7. FcRp72 from cultured monocytes is
sensitive to treatment with N-glycanase . Immuno-
precipitates ofCD 16 (A) andFcRp72 (B)from mon-
ocytes cultured for 10 d were prepared using 3G8
Fab-Sepharose and 32 IgG-Sepharose, respec-
tively, and then prepared as in Fig . 5 . CD16 and
FcRp72 were treated with buffer (lane 1) or N-
glycanase, 50 U/ml (lane 2) . Reaction mixtures
were then subjected to SDS-PAGE as in Fig . 4 .
decreased ^-3 kD with treatment with N-glycanase. Although neutrophil CD16
appears to be heavily glycosylated, monocyte CD16 appears to have little, if any,
carbohydrate . Therefore, differential glycosylation may account for the differ-
ences between CD16 from neutrophils and CD16 from monocytes apparent on
SDS-PAGE .
Discussion
We have studied the surface expression, functions, and structure of CD16 on
cultured monocytes, and have confirmed that expression of CD16 is develop-
mentally regulated . In contrast to two other FcRs, FcRp 2 and CDw32, CD16 is
absent from peripheral blood monocytes and increases with respect to both the
percentage of positive cells and cell surface density with length of time in culture.
In fact, by ^-2 wk in culture, CD16 is the predominant FcR on cell surfaces of
monocytes . Unlike expression of FcRp72, expression of CD16 usually does notCLARKSON AND CRY
￿
41 7
increase on cells incubated with IFN-y. This is similar to the regulation of low
density lipoprotein receptors, which also increase in number when human mon-
ocytes differentiate in culture, but which actually decrease in number when cells
are incubated with LPS or IFN (24). Thus, like the low density lipoprotein
receptor, CD16 may be a marker for normal cellular differentiation.
We currently cannot explain our observation that monocytes from two indi-
viduals could be induced to express CD16 with IFN-y. One explanation may
relate to a genetic polymorphism noted previously by Perussia et al. (4) in
expression of the antigenic determinant recognized by anti-CD16 mAb B73.1.
Although this mAb recognizes NK cells from all individuals, only ^-50% of
individuals express the epitope recognized by B73.1 on their neutrophils. We
are currently attempting to correlate reactivity of neutrophils with B73.1 and
induction of CD16 on cultured monocytes by IFN-y.
The relative importance of the three different FcRs in mediating immuno-
phagocytosis is not known. All three mediate rosetting with IgG-opsonized
erythrocytes in vitro, as determined by blockade using anti-CD16 and anti-
CDw32 mAbs (2, 25) or by blockade using high concentrations of monomeric
IgGI (in the case of FcRp72) (26). In previous studies, Fleit et al. (16) found that
rosetting with IgG-opsonized erythrocytes was inhibited by 70% when monocytes
were attached to surfaces coated with mAb 3G8. fungi and Hafner (27) also
found thatcultured monocytesbecome better able to phagocytose IgG-opsonized
particles with increasing length oftime in culture. This phenomenon paralleled
development oflow affinity IgG binding sites determined by Scatchard analysis.
Moreover, Wright et al. (28) found that stimulation ofcultured monocytes with
IFN-y, whichincreasesexpression ofFcRp72 (19), actuallydecreased phagocytosis
ofIgG-opsonized particles by cultured monocytes, suggesting that FcRp72 is not
critical for the ingestion of such particles. Based on the relative abundance of
CD16 on cultured monocytes, results of previous studies demonstrating a role
for CD16 in rosetting, and the relation between increased ability of cultured
monocytes to phagocytose IgG-opsonized particles and surface expression of
CD16, it is attractive to hypothesize that CD16 is the most important FcR on
macrophages for mediating immunophagocytosis. Our results support this hy-
pothesis, and suggest that while all three FcRs can mediate ligand attachment,
CD16 appears to play a more important role in mediating phagocytosis.
We also have investigated the structure of CD16 on both cultured monocytes
and neutrophils. Neutrophil CD16 appears to contain abundant N-linked car-
bohydrate. CD16 on cultured monocytes, however, appears to be glycosylated
to a lesser extent (if at all). Differential glycosylation has also been proposed to
explain apparent differences in M, between otherwise identical surface glycopro-
teins on different. cell types, presumably because of cell-specific expression of
giycosyltransferases (29). For example, Thy-1 from rat brain tissue and Thy-1
from rat lymphocytes are composed of nearly identical protein moieties, but
differ considerably in carbohydrate content (30). Differences in thecore proteins
may also account for these differences as has been noted with murine FcRs.
cDNA probes for murine FcRs for IgG2b/1 detect at least three different
transcripts in murine macrophages (31). Two ofthese transcriptsencode proteins
that differ slightly in length, but that react with anti-FcR2g/1 mAb 2AG2.41 8
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Therefore, the differences noted between CD16 on neutrophils on CD16 on
cultured monocytes may be due to either differential posttranslational modifi-
cation or differences at the level of transcription.
Summary
We have demonstrated thatone Fc receptor for IgG (FcR) (CD16) on cultured
human monocytesappears to be adevelopmentally regulated membrane protein.
This receptor appears to contain less carbohydrate (ifany) than does its counter-
parton human neutrophils. Expression ofCD16 on cultured monocytes increases
with respect to both percentage of positive cells and numbers of sites per cell
with length of time in culture. This was in contrast to expression of other types
of FcRs that either decreased (CDw32) or did not change (FcRp72). Unlike an
FcR that binds monomeric IgG (FcRp72), expression ofCD16 on monocytes from
most normal individuals was not influenced by IFN-7. After 14 d in culture,
CD16 appeared to be the predominant FcR on cultured monocytes, and was
capable of mediating both ligand attachment and phagocytosis. These findings
support the hypothesis that CD16 plays an important role in mediating immu-
nophagocytosis.
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